Results 131 to 140 of about 6,714 (194)

Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations. [PDF]

open access: yesLeukemia
Sakuma M   +9 more
europepmc   +1 more source

UBA6 specificity for ubiquitin E2 conjugating enzymes reveals a priority mechanism of BIRC6. [PDF]

open access: yesNat Struct Mol Biol
Riechmann C   +5 more
europepmc   +1 more source

Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence

open access: yesActa Pharmaceutica Sinica B
Jiaqing Yang   +6 more
openaire   +3 more sources

Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score. [PDF]

open access: yesJ Clin Immunol
von Bornemann Fløe L   +13 more
europepmc   +1 more source

Primary CD34<sup>+</sup> cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243. [PDF]

open access: yesBr J Haematol
Nowak D   +21 more
europepmc   +1 more source

UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice. [PDF]

open access: yesJ Clin Invest
Dong G   +15 more
europepmc   +1 more source

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms. [PDF]

open access: yesLeukemia
Thier J   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy